Federico Rotolo
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors.
Journal: Journal for immunotherapy of cancer
Published: August 03, 2026
Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort.
Journal: Therapeutic advances in medical oncology
Published: November 15, 2024
Describing quality of life trajectories in young Hispanic women with breast cancer: 5-year results from a large prospective cohort.
Journal: Breast (Edinburgh, Scotland)
Published: July 23, 2024
Avdoralimab (Anti-C5aR1 mAb) Versus Placebo in Patients With Severe COVID-19: Results From a Randomized Controlled Trial (FOR COVID Elimination [FORCE]).
Journal: Critical care medicine
Published: October 11, 2022
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.
Journal: Journal of hematology & oncology
Published: October 02, 2020
Predictive classifier for intensive treatment of head and neck cancer.
Journal: Cancer
Published: March 31, 2020
Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models.
Journal: BMC bioinformatics
Published: January 03, 2020
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Journal: The Lancet. Oncology
Published: March 08, 2019
Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 19, 2018
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 15, 2018
Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer.
Journal: Translational lung cancer research
Published: July 28, 2018
Last Updated: 09/26/2026